Logo

Biotique Licenses BLIS Informatics Platform to Bristol-Myers

Jul 09, 2002

NEW YORK, July 9 - Biotique Systems today said it has licensed its BLIS data-integration platform to Bristol-Myers Squibb.

 

The deal, sealed at the end of the last quarter, covers five BMS sites with some 2,000 employees, Biotique said. With the technology, BMS will be able to marry public genomic data with its in-house data.

 

Biotique, which counts as competitors Lion Bioscience and Compugen, has also licensed the BLIS platform to Berlex Biosciences.

 

Click here for more information.

Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.